Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.

Yamaguchi Y, Moriki T, Igari A, Matsubara Y, Ohnishi T, Hosokawa K, Murata M.

Thromb Res. 2013 Aug;132(2):263-70. doi: 10.1016/j.thromres.2013.05.026. Epub 2013 Jun 16.

PMID:
23777751
2.

A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.

Hosokawa K, Ohnishi T, Fukasawa M, Kondo T, Sameshima H, Koide T, Tanaka KA, Maruyama I.

Microvasc Res. 2012 Mar;83(2):154-61. doi: 10.1016/j.mvr.2011.11.007. Epub 2011 Dec 6.

3.

Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.

Arima Y, Kaikita K, Ishii M, Ito M, Sueta D, Oimatsu Y, Sakamoto K, Tsujita K, Kojima S, Nakagawa K, Hokimoto S, Ogawa H.

J Thromb Haemost. 2016 Apr;14(4):850-9. doi: 10.1111/jth.13256. Epub 2016 Feb 19.

PMID:
26773298
4.

Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Ito M, Kaikita K, Sueta D, Ishii M, Oimatsu Y, Arima Y, Iwashita S, Takahashi A, Hoshiyama T, Kanazawa H, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Hokimoto S, Yamabe H, Ogawa H.

J Am Heart Assoc. 2016 Jan 25;5(1). pii: e002744. doi: 10.1161/JAHA.115.002744.

5.

Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.

Nogami K, Ogiwara K, Yada K, Shida Y, Takeyama M, Yaoi H, Minami H, Furukawa S, Hosokawa K, Shima M.

J Thromb Haemost. 2016 Apr;14(4):667-74. doi: 10.1111/jth.13273. Epub 2016 Mar 15.

PMID:
27061057
6.

Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.

Hosokawa K, Ohnishi T, Sameshima H, Miura N, Ito T, Koide T, Maruyama I.

Thromb Haemost. 2013 Jan;109(1):102-11. doi: 10.1160/TH12-06-0441. Epub 2012 Nov 22.

PMID:
23179055
7.

Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.

Yamazaki M, Ohnishi T, Hosokawa K, Yamaguchi K, Yoneyama T, Kawashima A, Okada Y, Kitagawa K, Uchiyama S.

J Thromb Haemost. 2016 Sep;14(9):1788-97. doi: 10.1111/jth.13391. Epub 2016 Aug 3.

PMID:
27328457
8.

Use of a microchip flow-chamber system as a screening test for platelet storage pool disease.

Minami H, Nogami K, Ogiwara K, Furukawa S, Hosokawa K, Shima M.

Int J Hematol. 2015 Aug;102(2):157-62. doi: 10.1007/s12185-015-1819-8. Epub 2015 Jun 14.

PMID:
26072294
9.

Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Oimatsu Y, Kaikita K, Ishii M, Mitsuse T, Ito M, Arima Y, Sueta D, Takahashi A, Iwashita S, Yamamoto E, Kojima S, Hokimoto S, Tsujita K.

J Am Heart Assoc. 2017 Apr 24;6(4). pii: e005263. doi: 10.1161/JAHA.116.005263.

10.

Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.

Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W.

Thromb Haemost. 2000 Feb;83(2):316-21.

PMID:
10739392
11.

Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.

Ogawa S, Ohnishi T, Hosokawa K, Szlam F, Chen EP, Tanaka KA.

Br J Anaesth. 2013 Dec;111(6):1013-23. doi: 10.1093/bja/aet229. Epub 2013 Jun 20.

PMID:
23794670
13.

A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions.

Hosokawa K, Ohnishi T, Kondo T, Fukasawa M, Koide T, Maruyama I, Tanaka KA.

J Thromb Haemost. 2011 Oct;9(10):2029-37. doi: 10.1111/j.1538-7836.2011.04464.x.

14.

Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).

Kinsella JA, Tobin WO, Cox D, Coughlan T, Collins R, O'Neill D, Murphy RP, McCabe DJ.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e84-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.012. Epub 2012 Sep 13.

PMID:
22981273
15.

Microfluidic system for simultaneous optical measurement of platelet aggregation at multiple shear rates in whole blood.

Li M, Ku DN, Forest CR.

Lab Chip. 2012 Apr 7;12(7):1355-62. doi: 10.1039/c2lc21145a. Epub 2012 Feb 22.

PMID:
22358184
16.

Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.

Suades R, Padró T, Vilahur G, Badimon L.

Thromb Haemost. 2012 Dec;108(6):1208-19. doi: 10.1160/TH12-07-0486. Epub 2012 Nov 8.

PMID:
23138460
17.

Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.

Colace TV, Muthard RW, Diamond SL.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1466-76. doi: 10.1161/ATVBAHA.112.249789. Epub 2012 Apr 19.

18.
19.

Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.

Sugita C, Yamashita A, Moriguchi-Goto S, Furukoji E, Takahashi M, Harada A, Soeda T, Kitazawa T, Hattori K, Tamura S, Asada Y.

Thromb Res. 2009 Nov;124(5):601-7. doi: 10.1016/j.thromres.2009.06.035. Epub 2009 Aug 6.

PMID:
19660789
20.

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.

Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V.

Thromb Res. 2007;119(3):277-84. Epub 2006 Mar 24.

PMID:
16563469

Supplemental Content

Support Center